A Phase 1B Trial of Preoperative Eribulin and Radiation for Retroperitoneal Liposarcoma

Trial Profile

A Phase 1B Trial of Preoperative Eribulin and Radiation for Retroperitoneal Liposarcoma

Not yet recruiting
Phase of Trial: Phase I

Latest Information Update: 12 Mar 2018

At a glance

  • Drugs Eribulin (Primary)
  • Indications Liposarcoma
  • Focus Adverse reactions
  • Most Recent Events

    • 06 Mar 2018 Planned End Date changed from 4 Dec 2021 to 28 Feb 2022.
    • 06 Mar 2018 Planned primary completion date changed from 4 Dec 2019 to 28 Feb 2020.
    • 06 Mar 2018 Planned initiation date changed from 4 Dec 2017 to 1 Apr 2018.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top